The Latest Breaking News from Ben Rabizadeh

Is BioCryst (BCRX) Ready to Breakout to New Highs on Recent Catalysts?

By Ben Rabizadeh – Fundamentals well positioned with $1B peak sales forecast for Orladeyo and $300M influx of cash from royalty deals – Potential catalysts: update on Orladeyo sales with Q4 results on Feb. 23; BCX9930 trial enrollment underway and expect updates on progress

Benzinga · Feb 9, 2022

Will Growing Demand Help VirTra (VTSI) Outperform In A Potential Bear Market?

By Ben Rabizadeh Founder of Story, Inc. DBA StoryTrading – Several near-term catalysts possible, including contracts with U.S. and foreign governments 

Benzinga · Feb 2, 2022